Auregen BioTherapeutics SA
3D bioprinting technology for innovative treatments to cure rare disorders
Headquartered in Switzerland with facilities in Boston, Auregen is translating pioneering 3D bioprinting technology for innovative treatments for patients with rare disorders. By putting patients first, Auregen aspires to build a biotherapeutics platform focused on regenerative medicine that will change people’s lives.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No milestones
No Jobs
No videos and documents
No Awards
